Share

Polyendocrine Metabolic Ovarian Syndrome: New Name to Improve Diagnosis and Care of Condition Affecting 170 Million Women Worldwide 

Global effort changes the name of a significant women’s health condition that was misunderstood to be ‘all about ovarian cysts’ Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts one in eight, or more than 170 million women worldwide.  More than 50 patient and professional organizations, including the Endocrine...
Share

New Study Links Combination of Hormone Therapy and Tirzepatide to Greater Weight Loss after Menopause

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide. The findings, published in The Lancet Obstetrics, Gynaecology, & Women’s Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause. Menopause can accelerate age-related weight gain and increase the likelihood of...
Share

Endocrinologists Urged to Master Birth Control as Key Tool for Hormonal Health

A critical gap in medical knowledge is severely limiting care for patients with hormonal disorders: A new review in Endocrine Reviews delivers a wake-up call to endocrinologists, asserting that these specialists must drastically expand their training in contraception. The paper argues that hormonal birth control is a powerful, yet overlooked, weapon for managing complex metabolic...
Share

Reaching Out: Digital Advocacy in Women’s Hormonal Health

Omodamola Aje, MD, has built a social media platform to provide women with the tools they need to ask their doctors informed questions and help guide decisions in their treatment, from menopause to hypothyroidism. Aje is using her platform to not only help build a sense of community, but to cut through the rampant misinformation...
Share

Why High Testosterone Poses a Silent Threat to Women’s Hearts

A major shift is underway in women’s endocrine health that is changing how the medical community approaches Polycystic Ovary Syndrome (PCOS) and its link to cardiovascular risk. Recent findings published in the European Journal of Endocrinology, titled “Hyperandrogenaemia, Polycystic Ovary Syndrome, and Physical Fitness in Women—a Northern Finland Birth Cohort Study,” stem from a large...